Nearly half of patients admitted to the hospital for ankylosing spondylitis (AS) are discharged to somewhere other than home…
Margarida Maia PhD
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia PhD
While some people with recent-onset axial spondyloarthritis whose joint damage isn’t visible on an X-ray will progress within 10 years to ankylosing…
Adding Xeljanz (tofacitinib) to treatment with biologic disease-modifying anti-rheumatic drugs (DMARDs) when these medications aren’t working well may help…
High blood levels of two microRNAs, a type of small molecule involved in controlling which genes are turned…
A gene called NAT10 is less active in blood cells from people with new-onset ankylosing spondylitis…
Two or more comorbidities affected nearly half of the ankylosing spondylitis (AS) patients in a large study of the disease,…
People with ankylosing spondylitis (AS) who report more severe pain and disease activity, and poorer quality of life, continue…
A man with ankylosing spondylitis (AS) went into disease remission within three months of receiving BCD-180, an experimental antibody…
Note: This story was updated Oct. 31, 2023, to clarify that opioid use correlates with, rather than causes, an increased…
Children with one or more older siblings are up to 34% as likely as those who don’t have older siblings…